We are live on ! Find out more
MU

Mirova US Portfolio holdings

AUM $8.81B
1-Year Est. Return 21.38%
This Fund
S&P 500
This Quarter Est. Return
+3.27%
1 Year Est. Return
+21.38%
3 Year Est. Return
+80.7%
5 Year Est. Return
+106.85%
10 Year Est. Return
AUM
$4.28B
AUM Growth
+$556M
Cap. Flow
+$463M
Cap. Flow %
10.81%
Top 10 Hldgs %
66.52%
Holding
29
New
3
Increased
22
Reduced
2
Closed
2

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$43.7M
2
EBAY icon
eBay
EBAY
+$37.4M
3
TMO icon
Thermo Fisher Scientific
TMO
+$33.3M
4
DHR icon
Danaher
DHR
+$33.3M
5
MA icon
Mastercard
MA
+$32.6M

Top Sells

Rank Stock Value
1
ORA icon
Ormat Technologies
ORA
+$1.81M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.11M
3
XYL icon
Xylem
XYL
+$687K
4
WM icon
Waste Management
WM
+$456K

Sector Composition

Rank Sector Weight
1 Technology 31.97%
2 Healthcare 20%
3 Financials 15.02%
4 Consumer Discretionary 11.68%
5 Materials 6.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WM icon
26
Waste Management
WM
$96.1B
$1.27M 0.03%
8,540
-3,044
-26% -$456K
AVLR
27
DELISTED
Avalara, Inc.
AVLR
$726K 0.02%
+4,155
New +$714K
GOOG icon
28
Alphabet (Google) Class C
GOOG
$4.22T
-8,880
Closed -$1.11M
ORA icon
29
Ormat Technologies
ORA
$6.43B
-26,097
Closed -$1.81M

Similar funds

Mirova US's Q3 2021 Portfolio in Review

As of Q3 2021, Mirova US held 29 positions worth $4.28B, up 15% from $3.73B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Mirova US deployed $463M of net new capital in Q3 2021, opening 3 new positions and adding to 22 existing holdings. Its largest new stake was Sunrun: 106,407 shares worth $4.68M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Xylem, an estimated $687K trimmed.

  • Mirova US's largest Q3 2021 buy was Sunrun: 106,407 shares worth $4.68M.
  • Mirova US added most to Microsoft in Q3 2021, an estimated $43.7M increase.
  • Mirova US's biggest Q3 2021 reduction was Xylem, cutting an estimated $687K.
  • Mirova US fully exited Ormat Technologies in Q3 2021, selling an estimated $1.81M.
  • Mirova US's ten largest holdings make up 67% of its $4.28B portfolio in Q3 2021.
  • Mirova US opened 3 new positions and closed 2 in Q3 2021.
  • Mirova US's portfolio value rose 15% quarter-over-quarter to $4.28B.

Based on Mirova US's 13F filing for Q3 2021, filed 15 Nov 2021.